PT-141 (Bremelanotide) Price Comparison 2026
Melanocortin receptor agonist (Bremelanotide/Vyleesi®) studied for central sexual arousal pathways via MC3R/MC4R in the hypothalamus. FDA-approved for hypoactive sexual desire disorder. Acts on desire (brain) not blood flow — distinct mechanism from PDE5 inhibitors.
What Research Shows
Studied for MC3R/MC4R-mediated central sexual arousal via hypothalamic and mesolimbic dopamine pathways. FDA-approved Phase III human trial data available (n=394). Studies measure satisfying sexual events, FSFI score, and intromission latency (animal). Most clinically validated peptide in this guide.
PT-141 (Bremelanotide) SEA Price Comparison
Sorted by best price per mg. Click “Buy” to visit the vendor's product page. Verify prices before ordering — they change frequently.
| Vendor | Score | Best $/mg | SEA Ship. | |
|---|---|---|---|---|
| No vendors match your filters. | ||||
No vendors match your filters.
Compare Other Peptides
Want to compare vendors holistically — testing standards, purity, SEA shipping, and affiliate programs?
See Full SEA Vendor Comparison →